Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.04 | N/A | +2.97% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.04 | N/A | +2.97% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management acknowledged the tough market conditions but expressed commitment to maintaining operational efficiency. They did not provide specific guidance for the upcoming quarters.
Management highlighted ongoing challenges in the retail environment.
They emphasized a focus on cost management and efficiency.
No specific guidance was provided for future quarters.
Prestige Consumer HE's earnings report showed a small earnings beat, but the stock reacted negatively, dropping 8.8%. Investors may be concerned about the lack of revenue details and the absence of future guidance, which could indicate uncertainty in the company's outlook. The market's reaction suggests that investors were hoping for more positive news regarding revenue or future expectations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KONINKLIJKE PHILIPS ADR
Jan 30, 2023